These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21269600)

  • 41. Effects of naltrexone on food intake and body weight gain in olanzapine-treated rats.
    Kurbanov DB; Currie PJ; Simonson DC; Borsook D; Elman I
    J Psychopharmacol; 2012 Sep; 26(9):1244-51. PubMed ID: 22723540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of treatment algorithms including amantadine, metformin, and zonisamide for the prevention of weight gain with olanzapine: a randomized controlled open-label study.
    Hoffmann VP; Case M; Jacobson JG
    J Clin Psychiatry; 2012 Feb; 73(2):216-23. PubMed ID: 21672497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C.
    Lord CC; Wyler SC; Wan R; Castorena CM; Ahmed N; Mathew D; Lee S; Liu C; Elmquist JK
    J Clin Invest; 2017 Sep; 127(9):3402-3406. PubMed ID: 28805659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats.
    Snigdha S; Thumbi C; Reynolds GP; Neill JC
    J Psychopharmacol; 2008 Jul; 22(5):567-71. PubMed ID: 18208914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metformin and berberine prevent olanzapine-induced weight gain in rats.
    Hu Y; Young AJ; Ehli EA; Nowotny D; Davies PS; Droke EA; Soundy TJ; Davies GE
    PLoS One; 2014; 9(3):e93310. PubMed ID: 24667776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of famotidine addition on olanzapine-induced weight gain in first-episode schizophrenia patients: a double-blind placebo-controlled pilot study.
    Poyurovsky M; Tal V; Maayan R; Gil-Ad I; Fuchs C; Weizman A
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):332-6. PubMed ID: 15163444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of Ovarian Secretions Reverts the Anabolic Action of Olanzapine in Female Rats.
    Skrede S; González-García I; Martins L; Berge RK; Nogueiras R; Tena-Sempere M; Mellgren G; Steen VM; López M; Fernø J
    Int J Neuropsychopharmacol; 2017 Dec; 20(12):1005-1012. PubMed ID: 29020342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased lean body mass as an early indicator of olanzapine-induced weight gain in healthy men.
    Daurignac E; Leonard KE; Dubovsky SL
    Int Clin Psychopharmacol; 2015 Jan; 30(1):23-8. PubMed ID: 25350366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    Hum Psychopharmacol; 2003 Aug; 18(6):457-61. PubMed ID: 12923824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Samidorphan mitigates olanzapine-induced weight gain and metabolic dysfunction in rats and non-human primates.
    Cunningham JI; Eyerman DJ; Todtenkopf MS; Dean RL; Deaver DR; Sanchez C; Namchuk M
    J Psychopharmacol; 2019 Oct; 33(10):1303-1316. PubMed ID: 31294646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters.
    Davey KJ; O'Mahony SM; Schellekens H; O'Sullivan O; Bienenstock J; Cotter PD; Dinan TG; Cryan JF
    Psychopharmacology (Berl); 2012 May; 221(1):155-69. PubMed ID: 22234378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain.
    Weston-Green K; Huang XF; Han M; Deng C
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):827-35. PubMed ID: 18257959
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic olanzapine administration in rats: effect of route of administration on weight, food intake and body composition.
    Mann S; Chintoh A; Giacca A; Fletcher P; Nobrega J; Hahn M; Remington G
    Pharmacol Biochem Behav; 2013 Feb; 103(4):717-22. PubMed ID: 23234835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota.
    Kao AC; Spitzer S; Anthony DC; Lennox B; Burnet PWJ
    Transl Psychiatry; 2018 Mar; 8(1):66. PubMed ID: 29540664
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects: A Proof-of-Concept Study.
    Hunt HJ; Donaldson K; Strem M; Tudor IC; Sweet-Smith S; Sidhu S
    J Clin Psychopharmacol; 2021 Nov-Dec 01; 41(6):632-637. PubMed ID: 34369902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A role for hypothalamic AMP-activated protein kinase in the mediation of hyperphagia and weight gain induced by chronic treatment with olanzapine in female rats.
    Sejima E; Yamauchi A; Nishioku T; Koga M; Nakagama K; Dohgu S; Futagami K; Kataoka Y
    Cell Mol Neurobiol; 2011 Oct; 31(7):985-9. PubMed ID: 21681559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Olanzapine effects on body composition, food preference, glucose metabolism and insulin sensitivity in the rat.
    Smith GC; Vickers MH; Shepherd PR
    Arch Physiol Biochem; 2011 Oct; 117(4):241-9. PubMed ID: 21671852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities.
    Cooper GD; Pickavance LC; Wilding JP; Harrold JA; Halford JC; Goudie AJ
    J Psychopharmacol; 2007 Jun; 21(4):405-13. PubMed ID: 17050655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Profiling of energy metabolism in olanzapine-induced weight gain in rats and its prevention by the CB1-antagonist AVE1625.
    Liebig M; Gossel M; Pratt J; Black M; Haschke G; Elvert R; Juretschke HP; Neumann-Haefelin C; Kramer W; Herling AW
    Obesity (Silver Spring); 2010 Oct; 18(10):1952-8. PubMed ID: 20168311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.